| scholarly article | Q13442814 |
| P50 | author | John-David Aubert | Q37371357 |
| Glen P Westall | Q43587380 | ||
| P2093 | author name string | Sofya Tokman | |
| Michael Tamm | |||
| Joyce S Lee | |||
| Christine K Garcia | |||
| Jeffrey A Golden | |||
| Jonathan P Singer | |||
| Lorriana E Leard | |||
| Gregory I Snell | |||
| Jasleen Kukreja | |||
| Hilary J Goldberg | |||
| Steven R Hays | |||
| Megan S Devine | |||
| P2860 | cites work | Posttransplant lymphoproliferative disease after lung transplantation | Q36701511 |
| Bronchiolitis obliterans syndrome: the final frontier for lung transplantation | Q37911090 | ||
| Familial forms of nonspecific interstitial pneumonia/idiopathic pulmonary fibrosis: clinical course and genetic background | Q38025236 | ||
| Cytokine gene expression in rejecting and tolerant rat lung allograft models: analysis by RT-PCR | Q43438454 | ||
| Telomerase gene mutations are associated with cirrhosis formation | Q43444556 | ||
| The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Lung and Heart-Lung Transplant Report--2011. | Q44321946 | ||
| The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012. | Q44728184 | ||
| Voriconazole Prophylaxis in Lung Transplant Recipients | Q59230762 | ||
| A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group | Q71062352 | ||
| Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group | Q72242917 | ||
| Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome | Q73217622 | ||
| A new classification system for chronic lung allograft dysfunction | Q87008531 | ||
| Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy | Q26852788 | ||
| Pulmonary fibrosis: patterns and perpetrators | Q27694249 | ||
| An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management | Q28308246 | ||
| Association between telomere length in blood and mortality in people aged 60 years or older | Q29615532 | ||
| A spectrum of severe familial liver disorders associate with telomerase mutations | Q30913791 | ||
| Risk of hematologic toxicities in patients with solid tumors treated with everolimus: a systematic review and meta-analysis | Q33408931 | ||
| Short telomeres, telomeropathy, and subclinical extrapulmonary organ damage in patients with interstitial lung disease | Q33418691 | ||
| Severe hematologic complications after lung transplantation in patients with telomerase complex mutations | Q33419942 | ||
| Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations | Q33587591 | ||
| Lung transplantation in telomerase mutation carriers with pulmonary fibrosis | Q33826806 | ||
| Lung transplantation for pulmonary fibrosis in dyskeratosis congenita: Case Report and systematic literature review | Q33933652 | ||
| Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation | Q34387549 | ||
| Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia | Q34409487 | ||
| Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection | Q34728157 | ||
| Adult-onset pulmonary fibrosis caused by mutations in telomerase | Q35759839 | ||
| Telomere dysfunction, autoimmunity and aging. | Q35806766 | ||
| Telomere diseases | Q36107376 | ||
| Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. | Q36279396 | ||
| P433 | issue | 10 | |
| P921 | main subject | lung transplant | Q1637912 |
| P304 | page(s) | 1318-1324 | |
| P577 | publication date | 2015-05-11 | |
| P1433 | published in | The Journal of Heart and Lung Transplantation | Q2364382 |
| P1476 | title | Clinical outcomes of lung transplant recipients with telomerase mutations | |
| P478 | volume | 34 |
| Q39014952 | An Exome Sequencing Study to Assess the Role of Rare Genetic Variation in Pulmonary Fibrosis |
| Q36121684 | Association of Donor and Recipient Telomere Length with Clinical Outcomes following Lung Transplantation |
| Q54213046 | Clinical Genetics in Interstitial Lung Disease. |
| Q60907998 | Heterozygous gene mutation associated with familial idiopathic pulmonary fibrosis |
| Q56334451 | Impaired CMV Immunity in Idiopathic Pulmonary Fibrosis Lung Transplant Recipients with Short Telomeres |
| Q26748519 | Lung transplantation at Duke |
| Q91651595 | Pilot experience of multidisciplinary team discussion dedicated to inherited pulmonary fibrosis |
| Q38995612 | Pulmonary fibrosis in the era of stratified medicine. |
| Q46801211 | Short lung transplant donor telomere length is associated with decreased CLAD-free survival |
| Q90638451 | Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis |
| Q40307232 | Telomere length in patients with pulmonary fibrosis associated with chronic lung allograft dysfunction and post-lung transplantation survival |
| Q33692595 | Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive |
| Q90428685 | Telomeres in Interstitial Lung Disease: The Short and the Long of It |
| Q93082066 | The Role of Telomerase and Telomeres in Interstitial Lung Diseases: From Molecules to Clinical Implications |
| Q91622811 | Translational research in pulmonary fibrosis |
| Q45875622 | Treatment of inherited bone marrow failure syndromes beyond transplantation. |
Search more.